Atricure Inc Quick Ratio (ATRC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Atricure Inc   (NASDAQ: ATRC)

Atricure Inc 's Quick Ratio

ATRC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Atricure Inc 's Cash & cash equivalent grew by 14.79 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Atricure Inc 's Quick Ratio to 2.05, Quick Ratio remained below Atricure Inc average.

Within Medical Equipment & Supplies industry 82 other companies have achieved higher Quick Ratio than Atricure Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1179 to 1242.

Explain Quick Ratio?
How much Cash & cash equivalents ATRC´s has?
What are ATRC´s Current Liabilities?




ATRC Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 18.99 % 19.55 % 11.03 % 4.58 % 12.44 %
Y / Y Cash & cash equivalent Change 42.44 % 46.33 % 36.43 % 13.45 % 3.31 %
Quick Ratio MRQ 2.05 2 2.05 1.9 1.71
ATRC's Total Ranking # 1242 # 1179 # 1085 # 1018 # 0
Seq. Current Liabilities Change 11.92 % -10.22 % 4.73 % 13.07 % 12.45 %
Seq. Cash & cash equivalent Change 14.79 % -12.7 % 13.23 % 25.53 % 17.93 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 83
Healthcare Sector # 499
Overall Market # 1242


Quick Ratio Statistics
High Average Low
6.11 2.07 0.89
(Jun 30 2020)   (Mar 31 2016)




Financial Statements
Atricure Inc 's Current Liabilities $ 82 Millions Visit ATRC's Balance sheet
Atricure Inc 's Cash & cash equivalent $ 168 Millions Visit ATRC's Balance sheet
Source of ATRC's Sales Visit ATRC's Sales by Geography


Cumulative Atricure Inc 's Quick Ratio

ATRC's Quick Ratio for the trailling 12 Months

ATRC Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 13.15 % 11.5 % 7.06 % 3.63 % -0.6 %
Y / Y Cash & cash equivalent TTM Growth 33.67 % 24.05 % 12.67 % 0.14 % -3.99 %
Quick Ratio TTM 2 1.92 1.84 1.74 1.69
Total Ranking TTM # 3882 # 3765 # 2904 # 2943 # 0
Seq. Current Liabilities TTM Growth 4.34 % 4.14 % 2.88 % 1.23 % 2.82 %
Seq. Cash & cash equivalent TTM Growth 8.63 % 8.68 % 9.16 % 3.72 % 0.81 %


On the trailing twelve months basis ATRC Cash & cash equivalent soared by 42.44 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Atricure Inc 's Quick Ratio to 2, Quick Ratio remained below ATRC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 197 other companies have achieved higher Quick Ratio than Atricure Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3765 to 3882.

Explain Quick Ratio?
How much Cash & cash equivalents ATRC´s has?
What are ATRC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 198
Healthcare Sector # 883
Within the Market # 3882


trailing twelve months Quick Ratio Statistics
High Average Low
4.92 2.11 1.08
(Mar 31 2021)   (Dec 31 2017)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions
Vivani Medical Inc   2.99 $ 19.894  Millions$ 6.659  Millions
Retractable Technologies Inc  2.98 $ 39.870  Millions$ 13.365  Millions
Neuropace Inc   2.97 $ 51.700  Millions$ 17.433  Millions
Apyx Medical Corp  2.95 $ 27.617  Millions$ 9.354  Millions
Omada Health Inc   2.94 $ 221.712  Millions$ 75.483  Millions
Clearpoint Neuro Inc   2.85 $ 29.363  Millions$ 10.313  Millions
Penumbra Inc  2.82 $ 658.795  Millions$ 233.776  Millions

Date modified: 2026-09-26T07:10:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.